Patents by Inventor Gregory Rigdon

Gregory Rigdon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment methods using triaryl methane compounds
    Publication number: 20070185209
    Abstract: The use of novel inhibitors of potassium flux is disclosed for the treatment of inflammatory processes, such as multiple sclerosis, insulin-dependent (type I) diabetes mellitus, rheumatoid arthritis, peripheral neuritis and pulmonary hypertension. The compounds are also of use in treating and preventing stroke. These inhibitors have a high specificity for the IK1 channel and greater stability relative to non-fluorine substituted homologues.
    Type: Application
    Filed: December 20, 2006
    Publication date: August 9, 2007
    Applicant: Icagen, Inc.
    Inventors: Neil Castle, Gregory Rigdon, Douglas Krafte